Structural findings in complement factor H-related proteins unravel the pathogenesis of C3 glomerulopathy

Structural findings in complement factor H-related proteins unravel the pathogenesis of C3 glomerulopathy

Detalhes bibliográficos
Main Authors:	de Jorge, E, Caeser, J, Malik, T, Patel, M, Colledge, M, Johnson, S, Harris, C, Pickering, M, Lea, S
Formato:	Conference item
Publicado em:	2012

Registos relacionados

Dimerization of complement factor H-related proteins modulates complement activation in vivo.
Por: Goicoechea de Jorge, E, et al.
Publicado em: (2013)

Complement Pathway Associated Glomerulopathies
Por: Yasar Caliskan
Publicado em: (2016-01-01)

Diabetic Glomerulopathy: Pathogenesis and Management
Por: Schmidt Susanne, et al.
Publicado em: (2000-01-01)

Pathogenesis, histopathologic findings and treatment modalities of lipoprotein glomerulopathy: A review
Por: Eduardo Cambruzzi, et al.
Publicado em: (2018-11-01)

Glomerular Complement Factor H–Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal Impairment
Por: Nicholas R. Medjeral-Thomas, et al.
Publicado em: (2019-10-01)

Steroid-Sensitive Complement 3 Glomerulopathy and Coronavirus Disease 2019
Por: Baris Eser, et al.
Publicado em: (2023-10-01)

Unraveling the Intricate Web: Complement Activation Shapes the Pathogenesis of Sepsis-Induced Coagulopathy
Por: Xin Wei, et al.
Publicado em: (2024-05-01)

New Aspects of Pathogenesis and Treatment of Membranous Glomerulopathy After the MENTOR Study
Por: Maurizio Salvadori, et al.
Publicado em: (2020-07-01)

Efficacy of Eculizumab in Coexisting Complement C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome
Por: Marco Busutti, et al.
Publicado em: (2021-02-01)

Acquired partial lipodystrophy and C3 glomerulopathy: Dysregulation of the complement system as a common mechanism
Por: Fernando Corvillo, et al.
Publicado em: (2018-05-01)

Viral Glomerulopathy
Por: Margaret Deoliveira, et al.
Publicado em: (2023-08-01)

C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3- and C5-Convertases
Por: Fei Zhao, et al.
Publicado em: (2019-05-01)

Pathogenesis and Management of Acute Kidney Injury in Patients with Nephrotic Syndrome Due to Primary Glomerulopathies
Por: Sophia Lionaki, et al.
Publicado em: (2019-07-01)

Glomerulopathy Associated with Visceral leishmaniasis
Por: Sh Khademvatan, et al.
Publicado em: (2007-03-01)

A new complement factor B mutation associated with crescentic C3 glomerulopathy; a case report
Por: Sofia Semedo Coelho, et al.
Publicado em: (2019-07-01)

Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy
Por: Sophie Chauvet, et al.
Publicado em: (2018-10-01)

The Spectrum of Glomerulopathy in Jordan
Por: Said Riyad, et al.
Publicado em: (2000-01-01)

Autoimmune Thyroiditis and Glomerulopathies
Por: Domenico Santoro, et al.
Publicado em: (2017-06-01)

Use of rituximab in glomerulopathies
Por: Cristiane Bitencourt Dias, et al.
Publicado em: (2022-02-01)

Histological pattern of glomerulopathies
Por: Noor Mohammad, et al.
Publicado em: (2012-07-01)

Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics
Por: Eleni Gavriilaki, et al.
Publicado em: (2019-02-01)

Putting the structure into complement.
Por: Lea, S, et al.
Publicado em: (2012)

Advances in collagen fibrosis glomerulopathy
Por: Zhang Hong-wen
Publicado em: (2025-02-01)

Pathology of C3 Glomerulopathy
Por: Su-Jin Shin, et al.
Publicado em: (2019-10-01)

Schistosoma mansoni associated glomerulopathy
Por: BRITO T. DE, et al.
Publicado em: (1999-01-01)

Segmental Membranous Glomerulopathy in Adults
Por: Shuangshuang Zhu, et al.
Publicado em: (2023-08-01)

Cytomegalovirus glomerulopathy in renal allografts
Por: Macaulay Amechi Chukwukadibia Onuigbo
Publicado em: (2020-01-01)

Glomerulopathy Associated With Moderate Obesity
Por: Yusuke Okabayashi, et al.
Publicado em: (2016-11-01)

Utility of Immunofluorescence in the Diagnosis of Glomerulopathies
Por: Rolando Teruel Ginés, et al.
Publicado em: (2021-09-01)

Collagen Type III Glomerulopathy
Por: AnnaLisa V. Wilson, et al.
Publicado em: (2021-06-01)

Rituximab in treatment of idiopathic glomerulopathy
Por: Kamel El-Reshaid, et al.
Publicado em: (2012-01-01)

Unravelling the pathogenesis of myasthenia gravis.
Por: Vincent, A
Publicado em: (2002)

Complement Activation: An Emerging Player in the Pathogenesis of Cardiovascular Disease
Por: Angela M. Carter
Publicado em: (2012-01-01)

Targeted MRM Quantification of Urinary Proteins in Chronic Kidney Disease Caused by Glomerulopathies
Por: Alexey S. Kononikhin, et al.
Publicado em: (2023-04-01)

De Novo Collapsing Glomerulopathy in a Renal Allograft Recipient
Por: Kanodia K, et al.
Publicado em: (2008-01-01)

Competition between antagonistic complement factors for a single protein on N. meningitidis rules disease susceptibility
Por: Joseph JE Caesar, et al.
Publicado em: (2014-12-01)

THE OF IMMUNOFLUORESCENCE IN DIAGNOSIS AND PROGNOSIS OF GLOMERULOPATHIES WITH EXTRACAPILLARY PROLIFERATION
Por: Dmitrieva M. V., et al.
Publicado em: (2020-12-01)

Comparative analysis of primary and secondary glomerulopathies in the northeast of Brazil: data from the Pernambuco Registry of Glomerulopathies - REPEG
Por: Denise Maria do Nascimento Costa, et al.

Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies
Por: Markus A. Loeven, et al.
Publicado em: (2021-08-01)

Further structural insights into the binding of complement factor H by complement regulator-acquiring surface protein 1 (CspA) of Borrelia burgdorferi.
Por: Caesar, J, et al.
Publicado em: (2013)